Literature DB >> 7014312

Evidence for a new cause of defective plasma removal of very low density lipoproteins in insulin-deficient rats.

H Bar-On, Y D Chen, G M Reaven.   

Abstract

These studies were initiated to see if factors other than reduced lipoprotein lipase activity might contribute to the defect in plasma removal of very low density lipoprotein (VLDL) that is observed in insulin-deficient rats. VLDL-triglyceride (TG) was labeled in vivo with 3H-glycerol in control and diabetic rats, and aliquots of plasma containing 3H-VLDL were injected into normal recipient rats. The half-time (t 1/2) of removal was almost twice as long when plasma from diabetic rats was injected, and this was true when the diabetic rats were fed either sucrose or regular chow. A comparable increase in t 1/2 was observed when 3H-VLDL isolated from normal rats was recombined with VLDL-free plasma from control and diabetic rats and injected into normal recipients. As before, the changes observed were not dependent upon antecedent diet. However, no significant difference in t 1/2 was observed when 3H-VLDL was isolated from control and diabetic rats and injected into normal recipients. Thus, there appears to be a factor present in VLDL-free plasma obtained from diabetic rats that interferes with removal of VLDL from the vascular compartment. Whether this factor is found in diabetic plasma in vivo, or is transferred from diabetic VLDL to diabetic plasma in the isolation procedure, remains to be clarified. In either event, there appears to be a factor, other than reduced LPL activity, that may play a role in the defect of VLDL-TG removal seen in insulin deficiency.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014312     DOI: 10.2337/diab.30.6.496

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  3 in total

1.  Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.

Authors:  R W Davies; I Staprans; F N Hutchison; G A Kaysen
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

2.  Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice.

Authors:  T Ebara; K Conde; Y Kako; Y Liu; Y Xu; R Ramakrishnan; I J Goldberg; N S Shachter
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

3.  Catabolism of very low density lipoproteins in experimental nephrosis.

Authors:  D W Garber; B A Gottlieb; J B Marsh; C E Sparks
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.